T315I MUTATION TREATMENT
REGISTEREDCombined Mark
Never miss important updates for T315I MUTATION TREATMENT
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach
Ownership
KT
Address
100 Boul. Alexis-neon
Saint-laurent, H4M2P2
Canada
Critical Dates
First Use Date
Not filed yet
Filing Date
Jan 15, 2021
Registration Date
Sep 2, 2025
Mark Descriptions
Goods
Medical testing for diagnostic and prognostic purposes in the field of cancer, kinase inhibitor treatment failure, and genetics; Medical testing for diagnostic and treatment purposes in the field of cancer research, kinase inhibitor treatment failure research, and genetics research; Providing medical information to medical professionals, namely, oncologists and treating physicians for cancer patients, in the form of reports in the field of cancer diagnostics and prognostics; Medical testing services, namely, kinase inhibitor treatment failure and genetic testing for diagnosis and treatment of cancer; Genetic testing for medical purposes; "T315I MUTATION TREATMENT"; Providing scientific analysis and informational reports based upon results of laboratory testing in the field of kinase inhibitor treatment failure, genetics, epigenetics and cancer; Scientific research in the fields of kinase inhibitor treatment failure, genetics, epigenetics and cancer; Laboratory research in the field of the field of cancer research, kinase inhibitor treatment failure, and genetics; Providing laboratory research services in the field of kinase inhibitor treatment failure and genetic testing
Mark Elements
Text Mark
T315I MUTATION TREATMENT
Category
Service Mark
Standard Characters
No
Color Claim
Yes
Color Details
The color(s) grey, purple and orange is/are claimed as a feature of the mark.
Design Search Codes
090104
241706
Trademark Timeline
Filing Date
Publication Date
Registration Date
USPTO Records
No documents found for this trademark.